Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial A Bastidas, J De La Serna, M El Idrissi, L Oostvogels, P Quittet, ... Jama 322 (2), 123-133, 2019 | 194 | 2019 |
A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute … AK Stewart, S Trudel, NJ Bahlis, D White, W Sabry, A Belch, T Reiman, ... Blood, The Journal of the American Society of Hematology 121 (9), 1517-1523, 2013 | 149 | 2013 |
Platelet microparticles and cancer: an intimate cross-talk H Goubran, W Sabry, R Kotb, J Seghatchian, T Burnouf Transfusion and Apheresis Science 53 (2), 168-172, 2015 | 75 | 2015 |
A randomized phase III trial of thalidomide and prednisone as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM … AK Stewart, S Trudel, NJ Bahlis, DJ White, W Sabry, A Belch, T Reiman, ... Blood 116 (21), 39, 2010 | 70 | 2010 |
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12 J Kuruvilla, DA MacDonald, CT Kouroukis, M Cheung, HJ Olney, ... Blood, The Journal of the American Society of Hematology 126 (6), 733-738, 2015 | 52 | 2015 |
Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of … W Sabry, R Le Blanc, AC Labbé, G Sauvageau, S Couban, T Kiss, ... Biology of Blood and Marrow Transplantation 15 (8), 919-929, 2009 | 52 | 2009 |
Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA) W Sabry, M Elemary, T Burnouf, J Seghatchian, H Goubran Transfusion and Apheresis Science 59 (1), 102717, 2020 | 35 | 2020 |
Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a … D Curran, S Matthews, SD Rowley, JAH Young, A Bastidas, ... Biology of Blood and Marrow Transplantation 25 (12), 2474-2481, 2019 | 31 | 2019 |
Blood and marrow transplantation in elderly acute myeloid leukaemia patients–older certainly is not better TL Kiss, W Sabry, HM Lazarus, JH Lipton Bone marrow transplantation 40 (5), 405-416, 2007 | 27 | 2007 |
Transfusion challenges in hematology oncology and hematopoietic stem cell transplant–literature review and local experience M Elemary, J Seghatchian, J Stakiw, M Bosch, W Sabry, H Goubran Transfusion and Apheresis Science 56 (3), 317-321, 2017 | 20 | 2017 |
BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy L Hahn, H Lim, T Dusyk, W Sabry, M Elemary, J Stakiw, P Danyluk, ... Scientific reports 11 (1), 14071, 2021 | 18 | 2021 |
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation I Ahmad, R LeBlanc, S Cohen, S Lachance, T Kiss, G Sauvageau, ... Bone Marrow Transplantation 51 (4), 529-535, 2016 | 17 | 2016 |
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial LE Budde, AJ Olszewski, S Assouline, IS Lossos, C Diefenbach, ... Nature Medicine 30 (1), 229-239, 2024 | 10 | 2024 |
Mosunetuzumab with polatuzumab vedotin is effective and has a manageable safety profile in patients aged< 65 and≥ 65 years with relapsed/refractory diffuse large B-cell … AJ Olszewski, LE Budde, J Chavez, N Ghosh, M Kamdar, IS Lossos, ... Blood 140 (Supplement 1), 3757-3759, 2022 | 10 | 2022 |
Reflections on multiple strategies to reduce transfusion in cancer patients: a joint narrative H Goubran, J Seghatchian, O Prokopchuk-Gauk, J Radosevic, W Sabry, ... Transfusion and Apheresis Science 56 (3), 322-329, 2017 | 9 | 2017 |
Platelet and extracellular vesicles in COVID-19 infection and its vaccines H Goubran, J Seghatchian, W Sabry, G Ragab, T Burnouf Transfusion and Apheresis Science 61 (3), 103459, 2022 | 8 | 2022 |
Mosunetuzumab Plus Polatuzumab Vedotin Demonstrates a Favorable Safety Profile and Efficacy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL … LE Budde, AJ Olszewski, S Assouline, IS Lossos, C Diefenbach, ... Blood 142, 613, 2023 | 6 | 2023 |
Transplant-associated thrombotic microangiopathy: diagnostic challenges and management strategies M Elemary, W Sabry, J Seghatchian, H Goubran Transfusion and Apheresis Science 58 (3), 347-350, 2019 | 6 | 2019 |
Viral infections in allogeneic hematopoietic stem cell transplant recipients: literature review S Kodad, W Sabry, A Elsayed, H Goubran, M Elemary OBM Transplantation 3 (3), 1-22, 2019 | 4 | 2019 |
Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach W Sabry, Y Wu, SG Kodad Current Oncology 29 (7), 5042-5053, 2022 | 2 | 2022 |